The Beta Galactocerebrosidase (GALC), Blood test measures the activity of the galactocerebrosidase (GALC) enzyme in blood. Deficiency of this enzyme is primarily associated with Krabbe disease (Globoid Cell Leukodystrophy), a rare inherited lysosomal storage disorder that affects the nervous system.
When is this test recommended?
Developmental delay or regression in infants
Muscle stiffness (spasticity) or weakness
Feeding difficulties
Unexplained seizures
Vision or hearing impairment
Peripheral neuropathy
Family history of Krabbe disease
Follow-up after abnormal newborn screening
Evaluation before confirmatory genetic testing
Why is this test important?
Helps diagnose Krabbe disease early
Differentiates enzyme deficiency from other neurological disorders
Assists in identifying individuals who may require GALC gene testing
Supports early treatment planning, including consideration for hematopoietic stem cell transplantation in eligible patients
Sample Required
Sample Type: Whole Blood
Container: EDTA Tube
Preparation
No fasting is required.
Inform your healthcare provider about any recent blood transfusions or bone marrow transplantation, as these may influence test interpretation.
Understanding the Results
Low or Absent GALC Activity: Suggestive of Krabbe disease; confirmatory molecular testing (GALC gene analysis) and clinical correlation are recommended.
Normal GALC Activity: Krabbe disease is unlikely, though additional evaluation may be needed if clinical suspicion remains high.
Who should consider this test?
Infants with symptoms suggestive of Krabbe disease
Individuals with a family history of Krabbe disease
Patients with unexplained neurological symptoms
Individuals with positive newborn screening results
Siblings or relatives of affected patients
Benefits
Enables early diagnosis of a rare genetic disorder
Supports timely clinical intervention
Guides confirmatory genetic testing
Assists in family counseling and future pregnancy planning
Note: Test results should always be interpreted along with the patient's clinical findings, family history, and, when indicated, confirmatory genetic testing.